Narmadaria Laboratories Profile
Key Indicators
- Authorised Capital ₹ 0.10 M
- Paid Up Capital ₹ 0.10 M
- Company Age 7 Year, 5 Months
- Last Filing with ROC 31 Mar 2023
- Revenue Growth %
- Profit Growth 38.45%
- Net Worth -0.96%
- Total Assets -0.10%
About Narmadaria Laboratories
Narmadaria Laboratories Private Limited (NLPL) is a Private Limited Indian Non-Government Company incorporated in India on 25 August 2017 (Seven years and five months 10 days old ). Its registered office is in Guntur, Andhra Pradesh, India.
The Company is engaged in the Pharma Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2023. It's a company limited by shares with an authorized capital of Rs 0.10 M and a paid-up capital of Rs 0.10 M, as per Ministry of Corporate Affairs (MCA) records.
The Key Managerial Personnel (KMP) at Narmadaria Laboratories Private Limited India are Suneel Guntupalli as CFO and Srinivas Munduru as Ceo. Chirumamilla Rao, Narmada Chirumamilla, and Ashok Kamkananpati serve as directors at the Company.
Company Details
-
Location
Guntur, Andhra Pradesh, India
-
Telephone
+91-XXXXXXXXXX
-
Email Address
-
Website
-
-
Social Media-
Corporate Identity Details
-
CIN/LLPIN
U24304AP2017PTC106547
-
Company No.
106547
-
Company Classification
Private Limited Indian Non-Government Company
-
Incorporation Date
25 Aug 2017
-
Date of AGM
30 Sep 2023
-
Date of Balance Sheet
31 Mar 2023
-
Listing Status
Unlisted
-
ROC Code
Roc Vijayawada
Industry
Who are the key members and board of directors at Narmadaria Laboratories?
Executive Team (3)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Chirumamilla Rao
|
Managing Director | 25-Aug-2017 | Current |
|
Suneel Guntupalli
|
CFO | 20-Sep-2017 | Current |
|
Srinivas Munduru
|
CEO | 20-Sep-2017 | Current |
Board Members (2)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
|
Narmada Chirumamilla
|
Director | 25-Aug-2017 | Current |
|
Ashok Kamkananpati
|
Director | 25-Aug-2017 | Current |
Financial Performance of Narmadaria Laboratories.
Narmadaria Laboratories Private Limited, for the financial year ended 2023, experienced no change in revenue, with a 0% increase. The company also saw a substantial improvement in profitability, with a 38.45% increase in profit. The company's net worth dipped by a decrease of 0.96%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metrics |
|
(FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
|
||||||
| Revenue from Operations |
|
||||||
| Total Assets |
|
||||||
| Profit or Loss |
|
||||||
| Net Worth |
|
||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Narmadaria Laboratories?
In 2023, Narmadaria Laboratories had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
-
Greystone Mine Private LimitedChirumamilla Rao and Narmada Chirumamilla are mutual person
-
Amala Projects Private Limited
Chirumamilla Rao, Narmada Chirumamilla and 1 more are mutual person
-
East Coast Beach Resort Private Limited
Chirumamilla Rao is a mutual person
-
Andhra Digital Cable Network Private Limited
Chirumamilla Rao is a mutual person
-
Abhaya Cements Private Limited
Narmada Chirumamilla and Ashok Kamkananpati are mutual person
Charges (Loans)
There are no open charges registered against the company as per our records.
How Many Employees Work at Narmadaria Laboratories?
Unlock and access historical data on people associated with Narmadaria Laboratories, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Narmadaria Laboratories, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Narmadaria Laboratories's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
